Variant report
Variant | esv1801264 |
---|---|
Chromosome Location | chr2:234492805-234500262 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:0)
- Chromatin interactive region (count:23)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr2:234495653-234495913 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr2:234495601-234495908 | GM12878 | blood: | n/a | n/a |
3 | CEBPB | chr2:234493082-234493353 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr2:234493163-234493281 | A549 | lung: | n/a | n/a |
5 | CTCF | chr2:234494246-234494305 | LNCaP | prostate: | n/a | n/a |
6 | CTCF | chr2:234494271-234494410 | Spleen_OC | spleen: | n/a | n/a |
7 | CTCF | chr2:234495766-234495803 | GM10266 | blood: | n/a | n/a |
8 | FOXA1 | chr2:234492884-234493164 | HepG2 | liver: | n/a | n/a |
9 | IRF4 | chr2:234495571-234495944 | GM12878 | blood: | n/a | n/a |
10 | JUND | chr2:234499003-234499092 | HepG2 | liver: | n/a | n/a |
11 | MAFF | chr2:234499549-234499704 | HepG2 | liver: | n/a | chr2:234499631-234499649 |
12 | MAFK | chr2:234499566-234499749 | HepG2 | liver: | n/a | chr2:234499633-234499648 |
13 | MAFK | chr2:234499484-234499801 | HepG2 | liver: | n/a | chr2:234499633-234499648 |
14 | MAFK | chr2:234499515-234499730 | IMR90 | lung: | n/a | chr2:234499633-234499648 |
15 | MYC | chr2:234493289-234493432 | K562 | blood: | n/a | n/a |
16 | POLR2A | chr2:234494108-234494267 | A549 | lung: | n/a | n/a |
17 | RCOR1 | chr2:234499351-234499466 | K562 | blood: | n/a | n/a |
18 | STAT3 | chr2:234496714-234496842 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | TBL1XR1 | chr2:234495715-234495884 | GM12878 | blood: | n/a | n/a |
20 | YY1 | chr2:234495668-234495879 | GM12878 | blood: | n/a | n/a |
No data |
(count:23 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | 2:234498935-234505513..2:234683624-234705119 | K562 | blood: | |
2 | 2:234498935-234505513..2:234666975-234672018 | Hela-S3 | cervix: | |
3 | chr2:234495064..234497019-chr2:234498487..234500716,2 | K562 | blood: | |
4 | 2:234492023-234494396..2:234743181-234749667 | Hela-S3 | cervix: | |
5 | 2:234492023-234494396..2:234543708-234558325 | GM12878 | blood: | |
6 | 2:234498935-234505513..2:234743181-234749667 | Hela-S3 | cervix: | |
7 | 2:234498935-234505513..2:234954947-234965240 | Hela-S3 | cervix: | |
8 | 2:234498935-234505513..2:234572898-234594986 | K562 | blood: | |
9 | 2:234498935-234505513..2:234898811-234918017 | Hela-S3 | cervix: | |
10 | 2:234498935-234505513..2:234635414-234639782 | Hela-S3 | cervix: | |
11 | chr2:234495064..234497019-chr2:234498487..234500716,2 | K562 | blood: | |
12 | 2:234498935-234505513..2:234825998-234827518 | Hela-S3 | cervix: | |
13 | 2:234494396-234495604..2:234625307-234630376 | K562 | blood: | |
14 | 2:234494396-234495604..2:234898811-234918017 | K562 | blood: | |
15 | 2:234498935-234505513..2:234543708-234558325 | H1-hESC | embryonic stem cell: | embryo |
16 | 2:234494396-234495604..2:234743181-234749667 | Hela-S3 | cervix: | |
17 | 2:234494396-234495604..2:234572898-234594986 | K562 | blood: | |
18 | chr2:234475176..234476679-chr2:234491140..234493711,2 | MCF-7 | breast: | |
19 | 2:234492023-234494396..2:234954947-234965240 | Hela-S3 | cervix: | |
20 | 2:234494396-234495604..2:234666975-234672018 | K562 | blood: | |
21 | 2:234498935-234505513..2:234835115-234838817 | Hela-S3 | cervix: | |
22 | chr2:234492474..234494735-chr2:234496256..234497901,2 | K562 | blood: | |
23 | 2:234494396-234495604..2:234882053-234898292 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
UGT1A12P | TF binding region |
ENSG00000244474 | chromatin interactions |
ENSG00000085982 | chromatin interactions |
ENSG00000241635 | chromatin interactions |
ENSG00000144481 | chromatin interactions |
ENSG00000243135 | chromatin interactions |
ENSG00000123485 | chromatin interactions |
ENSG00000228949 | chromatin interactions |
ENSG00000241119 | chromatin interactions |
ENSG00000072080 | chromatin interactions |
ENSG00000242366 | chromatin interactions |
ENSG00000185038 | chromatin interactions |
ENSG00000244122 | chromatin interactions |
ENSG00000242515 | chromatin interactions |
ENSG00000234143 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540227500 | chr2:234492834-234492835 | Active TSS Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
2 | rs554456333 | chr2:234492842-234492843 | Active TSS Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
3 | rs140698004 | chr2:234492869-234492870 | Active TSS Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
4 | rs577416723 | chr2:234492877-234492878 | Active TSS Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
5 | rs191631526 | chr2:234492949-234492950 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
6 | rs28968500 | chr2:234492961-234492962 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
7 | rs141023663 | chr2:234492974-234492975 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
8 | rs544300852 | chr2:234493003-234493004 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
9 | rs569339079 | chr2:234493026-234493027 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
10 | rs4129945 | chr2:234493048-234493049 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs183868807 | chr2:234493055-234493056 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
12 | rs546234106 | chr2:234493056-234493057 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
13 | rs554876089 | chr2:234493079-234493080 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
14 | rs566808234 | chr2:234493123-234493124 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
15 | rs149828607 | chr2:234493179-234493180 | Active TSS Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
16 | rs534248078 | chr2:234493202-234493203 | Enhancers Active TSS Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
17 | rs144931451 | chr2:234493210-234493211 | Enhancers Active TSS Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
18 | rs574410534 | chr2:234493248-234493249 | Enhancers Active TSS Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
19 | rs528550173 | chr2:234493268-234493269 | Enhancers Active TSS Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
20 | rs142092458 | chr2:234493297-234493298 | Enhancers Active TSS Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
21 | rs368649042 | chr2:234493386-234493387 | Enhancers Active TSS Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
22 | rs537623536 | chr2:234493391-234493392 | Enhancers Active TSS Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
23 | rs76145205 | chr2:234493409-234493410 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
24 | rs568175163 | chr2:234493436-234493437 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
25 | rs17863749 | chr2:234493440-234493441 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
26 | rs955939 | chr2:234493494-234493495 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
27 | rs191247757 | chr2:234493514-234493515 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
28 | rs141434216 | chr2:234493561-234493562 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
29 | rs368708092 | chr2:234493562-234493563 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
30 | rs372298406 | chr2:234493594-234493595 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
31 | rs577345715 | chr2:234493639-234493640 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
32 | rs955938 | chr2:234493659-234493660 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs148809144 | chr2:234493663-234493664 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
34 | rs28968501 | chr2:234493669-234493670 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs556822312 | chr2:234493673-234493674 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
36 | rs576731187 | chr2:234493694-234493695 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
37 | rs143578548 | chr2:234493698-234493699 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
38 | rs148062747 | chr2:234493702-234493703 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
39 | rs529752917 | chr2:234493790-234493791 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
40 | rs150952849 | chr2:234493829-234493830 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
41 | rs373551053 | chr2:234493834-234493835 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs186726456 | chr2:234493836-234493837 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs4132954 | chr2:234493876-234493877 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs532466840 | chr2:234493880-234493881 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
45 | rs374744692 | chr2:234493980-234493981 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
46 | rs563019870 | chr2:234494055-234494056 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
47 | rs141720940 | chr2:234494077-234494078 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
48 | rs191536582 | chr2:234494118-234494119 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
49 | rs531410414 | chr2:234494125-234494126 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
50 | rs57768657 | chr2:234494133-234494134 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 22429812 | CNVD |
Bladder cancer | 21909424 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Mental retardation | 20152051 | CNVD |
Cancer | 21183584 | CNVD |
Albright''s disease | 22277900 | CNVD |
Brachydactyly-Mental Retardation Syndrome | 22470819 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Autism | 18414403 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:234486400-234494800 | Weak transcription | A549 | lung |
2 | chr2:234492200-234493000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
3 | chr2:234492200-234493200 | Active TSS | HUES6 Cell Line | embryonic stem cell |
4 | chr2:234492200-234493200 | Active TSS | K562 | blood |
5 | chr2:234492200-234493400 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
6 | chr2:234492400-234493200 | Enhancers | Liver | Liver |
7 | chr2:234493000-234493200 | Enhancers | HepG2 | liver |
8 | chr2:234493000-234494200 | Enhancers | Spleen | Spleen |
9 | chr2:234493200-234493600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr2:234493400-234493600 | Enhancers | Placenta | Placenta |
11 | chr2:234495000-234497000 | Enhancers | GM12878-XiMat | blood |
12 | chr2:234496600-234497000 | Enhancers | Fetal Intestine Small | intestine |
13 | chr2:234496600-234497600 | Enhancers | Fetal Intestine Large | intestine |
14 | chr2:234499000-234499400 | Bivalent Enhancer | HepG2 | liver |